Domestic pharma major Dr Reddy's Labs has said that a promoter group firm Dr Reddy's Laboratories Holdings has increased its stake in the company to 22.82 per cent through open market purchase.
Dr Reddy's Holdings acquired 1,95,348 equity shares representing 0.11 per cent stake in the company through open market transactions, Dr Reddy's Labs said in a disclosure to the Bombay Stock Exchange.
The market purchase of shares, for an amount of about Rs 11.36 crore, was conducted through DSP Merrill Lynch.
DSP Merrill Lynch itself has no stake in Dr Reddy's Holdings. Pursuant to the acquisition, the holding company's stake in Dr Reddy's Labs has increased to 22.82 per cent.
At the end of June, Dr Reddy's Holdings held 22.46 per cent stake in the company.
